European Journal of Neurology

Journal

Publication Venue For

  • Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.  28:4135-4145. 2021
  • Muscle MRI in Myotonic Dystrophy type 1 (DM1): refining muscle involvement and implications for clinical trials. 2021
  • Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?.  28:2115-2120. 2021
  • Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial 2021
  • Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases.  25:238-246. 2018
  • Galectin-3 and risk of ischaemic stroke: Reasons for Geographic and Racial Differences in Stroke cohort.  24:1464-1470. 2017
  • Gut microbiota in early pediatric multiple sclerosis: a case‚ąícontrol study.  23:1308-1321. 2016
  • Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.  20:87-94. 2013
  • An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease.  18. 2011
  • THE EFFECT OF COMPUTER EXPERIENCE, ANXIETY, AND ATTITUDES ON COMPUTERIZED COGNITIVE TEST PERFORMANCE AMONG OLDER ADULTS.  18:76-76. 2011
  • Coffee, ADORA2A, and CYP1A2: The caffeine connection in Parkinson's disease.  18:756-765. 2011
  • Lack of evidence for an association between UCHL1 S18Y and Parkinson's disease.  15:134-139. 2008
  • Executive functions and Alzheimer's disease: Problems and prospects.  3:5-15. 1996
  • International Standard Serial Number (issn)

  • 1351-5101
  • Electronic International Standard Serial Number (eissn)

  • 1468-1331